11 min read
Monthly FDA Guidance and Regulatory News Review - September 2026
This September 2026 regulatory update focuses on FDA’s new guidance on neonatal parenteral nutrition compounding and...
Join Veristat and ACER Therapeutics at the VEDS Scientific Meeting Day 2022
ACER Therapeutics Decentralized Study Design: A Phase 3 Clinical Study in Patients with COL3A1-Positive Vascular Ehlers-Danlos Syndrome to Determine Whether Celiprolol Delays the Onset of VEDS-related Clinical Events abstract has been accepted to the poster session.
The one-day in-person meeting will be held on Monday, August 29, 2022, from 8:00am – 5:00 pm in Paris, France, as part of The Marfan Foundation’s Science in Paris meeting. Follow the conference link (below) to learn more.
Conference Details
Website: https://thevedsmovement.org/